Posted by Clinical Lab Products | Jun 30, 2010 | Miscellaneous |
MarketResearch.com has announced the addition of Decision Resources’ new report “How to Enhance the Value of Antiviral Therapies Through Biomarkers and Diagnostics.”
Read MorePosted by Clinical Lab Products | Jun 29, 2010 | Molecular Diagnostics, Sexually Transmitted Diseases |
Abbott announced that it has received 510(k) clearance from the FDA to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation’s most prevalent sexually transmitted diseases (STDs), gonorrhea and chlamydia.
Read MorePosted by Clinical Lab Products | Jun 23, 2010 | Sexually Transmitted Diseases |
Abbott’s ARCHITECT HIV Ag/Ab Combo assay is the first test approved in the United States that can simultaneously detect both HIV antigen and antibodies.
Read MorePosted by Clinical Lab Products | Jun 22, 2010 | Cancer, Miscellaneous |
US Department of Health and Human Services Secretary Kathleen Sebelius today announced $250 million in new Affordable Care Act investments to support prevention activities and develop the nations public health infrastructure.
Read MorePosted by Clinical Lab Products | Jun 18, 2010 | Miscellaneous, Osteoporosis |
QIAGEN has announced that it has entered into an agreement with the Dutch molecular diagnostic component supplier Genome Diagnostics which covers the development and commercialization of 6 new tests until 2011.
Read More